pharma · Diabetes Mellitus, Type 2 · Pharmacokinetic trial
Boehringer Ingelheim
News and analysis for Boehringer Ingelheim on NovaPharmaNews — regulatory, clinical, and market coverage.
Binger Straße, Ingelheim am Rhein, Rhineland-Palatinate 55218, DE HQ
46,699 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Binger Straße, Ingelheim am Rhein, Rhineland-Palatinate 55218, DE
- Employees
- 46,699
- Programs
- 193
- Drugs
- 113
- Patents
- 25
News & analysis
NovaPharmaNews articles mentioning Boehringer Ingelheim — regulatory, clinical, and market coverage.
News and analysis for Boehringer Ingelheim on NovaPharmaNews — regulatory, clinical, and market coverage.